AGP Executive Report
Last update: 8 hours agoHIV Prevention Update: The injectable long-acting PrEP option Apretude (cabotegravir) is highlighted as a new HIV-1 prevention tool, given every two months after initiation doses, with approvals reported across many countries including Zimbabwe. Public Health & Medicines Safety: Zimbabwe’s medicines regulator recall alerts continue to ripple regionally, with Malawi warned about specific Nifedipine and Levodopa/Carbidopa batches linked to quality concerns. Sex Workers’ Health Access: Sex workers in Epworth received free HIV testing, PrEP and screening, while calling for legal reforms and stronger protection from violence and stigma. Drug Abuse Prevention: A Bulawayo community launch urged “sober, skilled youths” and practical skills as a way to curb drug and substance abuse. Workplace/Community Health: A global study estimates hundreds of millions of unintentional acute pesticide poisoning cases yearly, stressing higher risks for women farmers and the need for safer practices. Local Health System Pressure: Bulawayo’s waste-management dispute is framed as a public-health issue, with calls for better waste collection and safer environments.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
